Dr. Eoin Brennan is a Research Fellow at the Conway Institute, University College Dublin. Eoin graduated from University College Cork in 2004 with an honours degree in Genetics and in 2008 completed his PhD in Prof Peter Maxwell's laboratory at Queen's University Belfast, studying the genetic and epigenetic mechanisms of diabetic kidney disease. Eoin completed part of his PhD studies at Sequenom Inc., San Diego, on a collaborative project investigating DNA methylation in diabetic kidney disease. In 2009, Eoin moved to UCD to work with Profs. Catherine Godson and Finian Martin to study the genetics and signalling pathways implicated in diabetes and microvascular complications of diabetes. Eoin's research has primarily focused on investigating the pathophysiology of vascular complications of diabetes, including diabetic kidney disease (DKD) and diabetes-associated atherosclerosis (DAA). In 2014, Eoin commenced a 3-year ELEVATE Marie Curie Fellowship at the Baker IDI Heart and Diabetes Institute, Melbourne, Australia. During this time he worked with Prof. Mark Cooper to investigate endogenous lipid and micro-RNA therapeutics in complications of Diabetes, with a specific focus on targeting vascular lesions. Current research projects of interest include the use of micro-RNA and pro-resolving lipids as a therapeutic strategy in atherosclerosis and cardiovascular disease.
UNIVERSITY COLLEGE DUBLIN APPOINTMENTS
- Assistant Professor - Lecturer in Clinical PharmacologyUniversity College Dublin, School of Medicine, Ireland1 Jun 2018
- PhDQueen's University Belfast20 Sep 2005 - 15 Sep 2008
- Research FellowBaker IDI Heart and Diabetes Institute, Melbourne1 Jan 2014 - 31 Dec 2015
- BScUniversity College Cork
- PhDQueen's University of Belfast